Expertise in
10
conditions

Dr. Brandon Fisher

Radiation Oncology
3592 W 9000 S Ste 100, 
West Jordan, UT 
On Staff At
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
3592 W 9000 S Ste 100, 
West Jordan, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brandon Fisher is a Radiation Oncologist in West Jordan, Utah. Dr. Fisher is highly rated in 10 conditions, according to our data. His top areas of expertise are Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Small Cell Lung Cancer (SCLC). Dr. Fisher is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Midwestern University Chicago College Of Osteopath
Residency
Drexel University
Specialties
Radiation Oncology
Licenses
Radiology in UT
Board Certifications
American Board Of Radiology
Hospital Affiliations
Ogden Regional Medical Center
Lakeview Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Hcj Radiation Oncology
3592 W 9000 S Ste 100, West Jordan, UT 84088
Other Locations
Utah Cancer Specialists
700 W 800 N Ste 140, Orem, UT 84057
Holy Cross Radiation Oncology Davis
1600 W Antelope Dr, Layton, UT 84041
Ogden Clinic Professional Center North
4650 Harrison Blvd, Ogden, UT 84403

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Radiation
Study Phase: Phase 3
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: May 25, 2022
Intervention Type: Radiation
Study Phase: Phase 1
View 7 Less Clinical Trials

9 Total Publications

Cervical cancer: A global health crisis.
Cervical cancer: A global health crisis.
Journal: Cancer
Published: December 19, 2016
Similar Doctors
Expertise in
10
conditions
Dr. David Gaffney
Radiation Oncology
Expertise in
10
conditions
Dr. David Gaffney
Radiation Oncology

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (198.8 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Gaffney is a Radiation Oncologist in Salt Lake City, Utah. Dr. Gaffney is highly rated in 10 conditions, according to our data. His top areas of expertise are Cervical Cancer, Endometrial Cancer, Vulvar Cancer, and Breast Cancer. Dr. Gaffney is currently accepting new patients.

Expertise in
6
conditions
Dr. Jonathan Tward
Radiation Oncology
Expertise in
6
conditions
Dr. Jonathan Tward
Radiation Oncology

Radiation Oncology - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (198.8 miles away)
801-581-2396
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Tward is a Radiation Oncologist in Salt Lake City, Utah. Dr. Tward is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Reconstructive Urology Surgery. Dr. Tward is currently accepting new patients.

Expertise in
29
conditions
Dr. Ying Hitchcock
Radiation Oncology
Expertise in
29
conditions
Dr. Ying Hitchcock
Radiation Oncology

Huntsman Cancer Institute Rad. Onc.

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 (195.1 miles away)
801-581-8793
Experience:
32+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ying Hitchcock is a Radiation Oncologist in Salt Lake City, Utah. Dr. Hitchcock has been practicing medicine for over 32 years is highly rated in 29 conditions, according to our data. Her top areas of expertise are Tongue Cancer, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Undifferentiated Pleomorphic Sarcoma. Dr. Hitchcock is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fisher's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 65 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile